PMID- 24469614 OWN - NLM STAT- MEDLINE DCOM- 20140623 LR - 20150430 IS - 1572-0241 (Electronic) IS - 0002-9270 (Linking) VI - 109 IP - 5 DP - 2014 May TI - Prospective evaluation of adverse events following lower gastrointestinal tract EUS FNA. PG - 676-85 LID - 10.1038/ajg.2013.479 [doi] AB - OBJECTIVES: There are virtually no data concerning the risk of adverse events (AEs) following lower gastrointestinal (LGI) endoscopic ultrasound (EUS). Our aim was to determine the incidence and factors associated with AEs following LGI EUS fine needle aspiration (FNA). METHODS: We conducted a prospective cohort study at a tertiary referral center. Five hundred and sixty-three patients underwent LGI EUS FNA between 1 January 2004 and 1 January 2012. We analyzed the 502 patients who had complete follow-up. AE severity was graded (1-5) utilizing Common Terminology Criteria or Visual Analog Scale. AEs were assessed during the procedures, in clinical follow-up, during phone interviews conducted at 7-14 days, and final clinical and/or phone interviews at 2-4 months. RESULTS: AEs developed in 103 (20.5%) patients and were classified as grade 1, 2, 3, or 4 in 34 (6.8%), 41 (8.2%), 23 (4.6%), and 5 (1.0%) patients, respectively. Bleeding and pain were the commonest AEs. No deaths occurred. On multivariate analysis, AEs were associated with prior pain (odds ratio (OR): 3.83, 95% confidence interval (CI): 2.35-6.25), FNA from a site other than a lymph node (LN) or gut wall (OR: 2.26, 95% CI: 1.10-4.70), and malignant FNA cytology (OR: 1.80, 95% CI: 1.10-2.97); serious (grade 3-4) AEs were associated with prior pain (OR: 15.21, 95% CI: 5.04-45.85) and FNA from a site other than a LN or gut wall (OR: 3.25, 95% CI: 1.15-9.20). CONCLUSIONS: LGI EUS FNA is associated with a high rate of serious grades 3-4 AEs. This may reflect the total number of associated interventions and the frequency of underlying pathology and symptoms. FAU - Levy, Michael J AU - Levy MJ AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. FAU - Abu Dayyeh, Barham K AU - Abu Dayyeh BK AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. FAU - Fujii, Larissa L AU - Fujii LL AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. FAU - Boardman, Lisa A AU - Boardman LA AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. FAU - Clain, Jonathan E AU - Clain JE AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. FAU - Iyer, Prasad G AU - Iyer PG AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. FAU - Rajan, Elizabeth AU - Rajan E AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. FAU - Topazian, Mark D AU - Topazian MD AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. FAU - Wang, Kenneth K AU - Wang KK AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. FAU - Wiersema, Maurits J AU - Wiersema MJ AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. FAU - Gleeson, Ferga C AU - Gleeson FC AD - Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. LA - eng PT - Clinical Trial PT - Journal Article DEP - 20140128 PL - United States TA - Am J Gastroenterol JT - The American journal of gastroenterology JID - 0421030 SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Colon/*pathology MH - Colonic Diseases/epidemiology/etiology MH - Colonoscopy MH - Endoscopic Ultrasound-Guided Fine Needle Aspiration/*adverse effects MH - Female MH - Follow-Up Studies MH - Gastrointestinal Hemorrhage/epidemiology/etiology MH - Humans MH - Hypotension/epidemiology/etiology MH - Logistic Models MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Odds Ratio MH - Pain/epidemiology/etiology MH - Prospective Studies MH - Rectal Diseases/epidemiology/etiology MH - Rectum/*pathology MH - Risk Factors MH - Young Adult EDAT- 2014/01/29 06:00 MHDA- 2014/06/24 06:00 CRDT- 2014/01/29 06:00 PHST- 2013/09/27 00:00 [received] PHST- 2013/12/16 00:00 [accepted] PHST- 2014/01/29 06:00 [entrez] PHST- 2014/01/29 06:00 [pubmed] PHST- 2014/06/24 06:00 [medline] AID - ajg2013479 [pii] AID - 10.1038/ajg.2013.479 [doi] PST - ppublish SO - Am J Gastroenterol. 2014 May;109(5):676-85. doi: 10.1038/ajg.2013.479. Epub 2014 Jan 28.